The 2009-2014 World Outlook for Pharmaceutical Preparations Acting on the Respiratory System

Countries covered: Global This econometric study covers the world outlook for pharmaceutical preparations acting on the respiratory system across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for pharmaceutical preparations acting on the respiratory system. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Additional Information

This econometric study covers the world outlook for pharmaceutical preparations acting on the respiratory system across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

More Global Respiratory/Pulmonary Reports

Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 by GlobalData
Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 provides data ...

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 by GlobalData
Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 provides data on the ...

Lung Injury Global Clinical Trials Review, H1, 2012 by GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury ...

Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 by GlobalData
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 provides data on the Bronchopulmonary Dysplasia ...

Bronchospasm Global Clinical Trials Review, H1, 2012 by GlobalData
Bronchospasm Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2012 provides data on the Bronchospasm clinical trial scenario. ...

See all reports like this >>